{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:51:13Z","timestamp":1792234273777,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018543","name":"Natural Science Foundation of Tibet Autonomous Region","doi-asserted-by":"publisher","award":["XZ202401YD0022"],"award-info":[{"award-number":["XZ202401YD0022"]}],"id":[{"id":"10.13039\/501100018543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025JDRC0029"],"award-info":[{"award-number":["2025JDRC0029"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2026NSFSCZY0081"],"award-info":[{"award-number":["2026NSFSCZY0081"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016107","name":"Science and Technology Department of Tibet Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018552","name":"Science and Technology Plan Project of Taizhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Sichuan Province Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114896","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:24:21Z","timestamp":1774970661000},"page":"114896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Engineered microglial membrane-coated polydopamine-based nanomedicine for precise treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"394","author":[{"given":"Qianqian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshed","family":"Bozorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Shevtsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huile","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114896_bb0005","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.114896_bb0010","author":"World Health Organization"},{"key":"10.1016\/j.jconrel.2026.114896_bb0015","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2026.114896_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101580","article-title":"Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: a value of statistical life approach","volume":"51","author":"Nandi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jconrel.2026.114896_bb0025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer\u2019s disease","volume":"11","author":"Corbett","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114896_bb0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114896_bb0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114896_bb0040","doi-asserted-by":"crossref","first-page":"eade0293","DOI":"10.1126\/sciadv.ade0293","article-title":"Secreted endogenous macrosomes reduce abeta burden and ameliorate Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114896_bb0045","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","article-title":"Accelerating Alzheimer\u2019s therapeutic development: the past and future of clinical trials","volume":"186","author":"Boxer","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114896_bb0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.adk0830","article-title":"Side effects loom over Alzheimer's drugs","volume":"381","author":"Couzin-Frankel","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0055","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1126\/science.adj9255","article-title":"Immunotherapies for Alzheimer\u2019s disease","volume":"382","author":"Golde","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0060","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jconrel.2026.114896_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2026.114896_bb0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s44161-021-00014-4","article-title":"Blood-brain barrier link to human cognitive impairment and Alzheimer\u2019s disease","volume":"1","author":"Barisano","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2026.114896_bb0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114896_bb0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114896_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114896_bb0090","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802611795860942","article-title":"Gamma-secretase inhibitors and modulators for the treatment of Alzheimer\u2019s disease: disappointments and hopes","volume":"11","author":"Imbimbo","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114896_bb0095","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/WNL.0000000000207268","article-title":"Brain shrinkage in anti-beta-amyloid Alzheimer trials: neurodegeneration or pseudoatrophy?","volume":"100","author":"Barkhof","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2026.114896_bb0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-008-1207-7","article-title":"Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study","volume":"200","author":"Casey","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jconrel.2026.114896_bb0105","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1080\/17425247.2023.2245332","article-title":"Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood-brain barrier","volume":"20","author":"Wei","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114896_bb0110","doi-asserted-by":"crossref","first-page":"2004025","DOI":"10.1002\/advs.202004025","article-title":"Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release","volume":"8","author":"Ruan","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2026.114896_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh0609","article-title":"Microglia promote autoimmune inflammation via the noncanonical NF-kappaB pathway","volume":"7","author":"Jie","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114896_bb0120","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/s41591-024-03122-3","article-title":"Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer\u2019s disease","volume":"30","author":"Rosenzweig","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.114896_bb0125","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/cells11132091","article-title":"Microglia phenotypes in aging and neurodegenerative diseases","volume":"11","author":"Wendimu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114896_bb0130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte crosstalk in CNS inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2026.114896_bb0135","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","article-title":"Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease","volume":"11","author":"McQuade","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114896_bb0140","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \u201cself\u201d peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1126\/science.1106587","article-title":"Exploring and engineering the cell surface interface","volume":"310","author":"Stevens","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0150","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.114896_bb0155","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1016\/j.cell.2024.07.002","article-title":"The choroid plexus synergizes with immune cells during neuroinflammation","volume":"187","author":"Xu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114896_bb0160","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.114896_bb0165","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114896_bb0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbadis.2005.03.014","article-title":"RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling","volume":"1741","author":"Chaney","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2026.114896_bb0175","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbapap.2011.02.011","article-title":"Binding studies of truncated variants of the abeta peptide to the v-domain of the RAGE receptor reveal abeta residues responsible for binding","volume":"1814","author":"Gospodarska","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2026.114896_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206959","article-title":"Peptide-functionalized prussian blue nanomaterial for antioxidant stress and NIR photothermal therapy against Alzheimer\u2019s disease","volume":"19","author":"Song","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114896_bb0185","article-title":"NIR-II hydrogen-bonded organic frameworks (HOFs) used for target-specific amyloid-beta photooxygenation in an Alzheimer\u2019s disease model","volume":"61","author":"Zhang","year":"2022","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.114896_bb0190","doi-asserted-by":"crossref","first-page":"15220","DOI":"10.1002\/anie.202101033","article-title":"Hydrogen atom transfer from HOO(.) to ortho-quinones explains the antioxidant activity of polydopamine","volume":"60","author":"Guo","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.114896_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114896_bb0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41565-023-01533-w","article-title":"A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering","volume":"19","author":"Krishnan","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114896_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adl4458","article-title":"Restraining neuroinflammation in Alzheimer\u2019s disease","volume":"16","author":"Foley","year":"2023","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jconrel.2026.114896_bb0210","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","article-title":"The innate immunity protein IFITM3 modulates gamma-secretase in Alzheimer\u2019s disease","volume":"586","author":"Hur","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114896_bb0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0220","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.114896_bb0225","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated t cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114896_bb0230","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1038\/s41467-024-49790-0","article-title":"Single cell transcriptomes and multiscale networks from persons with and without Alzheimer\u2019s disease","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114896_bb0235","first-page":"19","article-title":"Immune cells: potential carriers or agents for drug delivery to the central nervous system","volume":"11","author":"Zhang","year":"2024","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.jconrel.2026.114896_bb0240","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","article-title":"SYK coordinates neuroprotective microglial responses in neurodegenerative disease","volume":"185","author":"Ennerfelt","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114896_bb0245","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.114896_bb0250","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","article-title":"Human microglial state dynamics in Alzheimer\u2019s disease progression","volume":"186","author":"Sun","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114896_bb0255","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1002\/alz.14298","article-title":"Microglial responses partially mediate the effect of abeta on cognition in Alzheimer\u2019s disease","volume":"20","author":"Madsen","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2026.114896_bb0260","first-page":"0180","article-title":"Pathological BBB crossing melanin-like nanoparticles as metal-ion chelators and neuroinflammation regulators against Alzheimer\u2019s disease","volume":"6","author":"Huang","year":"2023","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.jconrel.2026.114896_bb0265","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41467-018-04255-z","article-title":"A self-destructive nanosweeper that captures and clears amyloid beta-peptides","volume":"9","author":"Luo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114896_bb0270","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.apsb.2022.02.001","article-title":"Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer\u2019s disease treatment by anti-neuroinflammation and neuroprotection","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114896_bb0275","doi-asserted-by":"crossref","first-page":"1901555","DOI":"10.1002\/advs.201901555","article-title":"An \u201camyloid-beta cleaner\u201d for the treatment of Alzheimer\u2019s disease by normalizing microglial dysfunction","volume":"7","author":"Liu","year":"2020","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2026.114896_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan8821","article-title":"Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer\u2019s mouse model","volume":"361","author":"Choi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: from synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114896_bb0290","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2026.114896_bb0295","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1038\/s41467-023-42295-2","article-title":"Multivalent tau\/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density","volume":"14","author":"Shen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114896_bb0300","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/1389557520666200103100521","article-title":"Potent acetylcholinesterase inhibitors: potential drugs for Alzheimer\u2019s disease","volume":"20","author":"Akincioglu","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114896_bb0305","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jnnp.2006.099424","article-title":"Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer\u2019s disease","volume":"78","author":"Feldman","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jconrel.2026.114896_bb0310","article-title":"Natural polyphenolic nanodots for Alzheimer\u2019s disease treatment","volume":"36","author":"Yang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114896_bb0315","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","article-title":"Precision drug delivery to the central nervous system using engineered nanoparticles","volume":"9","author":"Gao","year":"2024","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114896_bb0320","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2026.114896_bb0325","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2026.114896_bb0330","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-170045","article-title":"Mouse models of Alzheimer\u2019s disease","volume":"57","author":"Esquerda-Canals","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.jconrel.2026.114896_bb0335","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.cell.2024.03.015","article-title":"Human iPSC 4R tauopathy model uncovers modifiers of tau propagation","volume":"187","author":"Parra Bravo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114896_bb0340","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.abp9556","article-title":"MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease","volume":"381","author":"Balusu","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl2992","article-title":"Modeling late-onset Alzheimer\u2019s disease neuropathology via direct neuronal reprogramming","volume":"385","author":"Sun","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114896_bb0350","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1038\/s41380-024-02565-x","article-title":"Thy1-ApoE4\/C\/EBPbeta double transgenic mice act as a sporadic model with Alzheimer\u2019s disease","volume":"29","author":"Qian","year":"2024","journal-title":"Mol. Psychiatry"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:49:12Z","timestamp":1779756552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":70,"alternative-id":["S0168365926002981"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114896","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered microglial membrane-coated polydopamine-based nanomedicine for precise treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114896"}}